RecruitingNCT03200379

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Enrollment

150,000 participants

Start Date

Jun 15, 2017

Study Type

OBSERVATIONAL

Conditions

Hepatitis C, Chronic

Summary

To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan

Eligibility

Plain Language Summary

Simplified for easier understanding

This is a national registry in Taiwan tracking patients with chronic hepatitis C (a long-term liver infection caused by the hepatitis C virus) who are being treated with direct-acting antiviral medications (DAAs) — the newer, highly effective oral pills that can cure hepatitis C — to monitor treatment outcomes and safety. **You may be eligible if...** - You are a patient with chronic hepatitis C - You are currently being treated with direct-acting antiviral (DAA) medications - You are willing to participate and provide written informed consent **You may NOT be eligible if...** - You are unwilling to join the study - You do not provide written informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERdirectly acting antivirals (DAAs)

Eligible subjects would be those CHC patients who receive approved DAA in the daily practice in Taiwan. No clinical developing medications will be allocated patients.

Locations(1)

HepatobiliaryDivision, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan

Kaohsiung City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03200379

Related Trials

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

NCT07037277106 locations

Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy

NCT051409419 locations

Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

NCT049435881 location

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

NCT058709691 location